Li-Based Nanoprobes with Boosted Photoluminescence for Temperature Visualization in NIR Imaging-Guided Drug Release.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39745046.
- Also identified by DOI 10.1021/acs.nanolett.4c05153.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Lanthanide-doped fluoride nanocrystals have emerged as promising tools in biomedicine, yet their applications are still limited by their low luminescence efficiency. Herein, we developed highly efficient lithium-based core-shell-shell (CSS) nanoprobes (NPs) featuring a rhombic active domain and a spherical inert protective shell. By introducing Yb<sup>3+</sup> as an energy transfer bridge and optimizing the CSS design, a remarkable 1643-fold enhancement in visible emission and a 33-fold increase in NIR emission are achieved compared to original nanoparticles. The upconversion quantum yield and brightness are 5-fold and 10-fold higher than those of typical sodium-based NPs, respectively, supported by the finite-difference time-domain simulations revealing stronger light absorption in rhombic LiYF<sub>4</sub>. Furthermore, the hydrophilic modification enabled the CSS NPs to conjugate with Rose Bengal hexanoic acid, thereby achieving upconversion-activated drug release. Meanwhile, the robust NIR emission of Yb<sup>3+</sup> allows for precise lifetime-based thermal mapping and high-resolution imaging, advancing the development of noninvasive clinical diagnostics and targeted cancer therapies.
Medical subject headings
- Nanoparticles
- Lithium